Wednesday Aug 30, 2023

NICE and redacted data, spironolactone for acne, and drugs with anticholinergic activity

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the September 2023 issue of DTB. They discuss concerns over redacted data in NICE appraisal documents ( They review a placebo-controlled study that assessed the use of spironolactone for women with acne ( The main article explores anticholinergic burden and the risk of cognitive decline, dementia and increased mortality associated with long-term use of drugs with anticholinergic activity (

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page ( If you want to contact us please email Thank you for listening.

Copyright 2023 All rights reserved.

Version: 20230822